| Serial Number | 88581014 |
| Word Mark | ENLIGHTEN HEALTH |
| Filing Date | Thursday, August 15, 2019 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, July 4, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, April 6, 2021 |
| Goods and Services | Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devices; financial administration of patient reimbursement programs |
| Goods and Services | Business consultancy, business management consultancy, business strategy advisory and marketing services for pharmaceutical, medical device, food and healthcare companies; business consulting services, business strategy advisory services and marketing services relating to the development, formulation and testing of pharmaceuticals, bio-technology products and medical devices; business consulting services, business strategy advisory services and marketing services relating to conducting of clinical trials; business consulting services, business strategy advisory services and marketing services relating to the commercialization of pharmaceutical products, bio-technological products or medical devices; business consulting services, business strategy advisory services and marketing services relating to lead candidate drug optimization; business organization consultancy; retail store and wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; personnel recruitment; business project management services in the fields of clinical and non-clinical programs, clinical and non-clinical drug development and research studies, clinical and non-clinical trials or proof of concept trials; business consultation in the nature of design and development of market access strategies; implementation of market access strategies and processes on behalf of others for business purposes; business data analysis and reporting, review and analysis of medical and clinical data for third parties and providing a report on the meaning of such data to third parties for business cost analysis; business consultation services in the market authorization of drugs; commercial administration of the licensing of the goods and services of others; compilation of information into computer databases; business advisory services, business consultancy services, business data analysis, business information services, business management consulting, business strategy services, market research, marketing services, database management, and business project management services, all in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; business management services, namely, supply and demand forecasting drug supplies for clinical trials; business management services, namely, recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; Business services provided to the health care industry, namely, consulting services, market intelligence, data collection, data submission and patient management; holding company services, namely, providing ownership cost analyses, financial control audits, and business information reporting services for subsidiaries and affiliates; holding company services, namely, providing business management and business administration services for subsidiaries and affiliates |
| Goods and Services | Advisory services relating to regulatory compliance in the fields of pharmaceuticals and medical devices; monitoring of regulatory compliance in non-clinical and clinical pharmaceutical and medical device trials; investigation of assets, preparation and review of reports and assessments for regulatory purposes; providing information and advice regarding regulatory compliance; regulatory compliance consulting in the fields of pharmaceuticals and medical devices; regulatory compliance consulting in the field of obtaining government authorization to market pharmaceuticals and medical devices |
| Disclaimer with Predetermined Text | "HEALTH" |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, August 31, 2019 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 036 - Insurance; financial affairs; monetary affairs; real estate affairs. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, August 31, 2019 |
| Primary Code | 036 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, August 31, 2019 |
| Primary Code | 045 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Laboratory Corporation of America Holdings |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, NC 27215 |
| Party Name | Laboratory Corporation of America Holdings |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Burlington, NC 27215 |
| Event Date | Event Description |
| Tuesday, July 5, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, July 4, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, December 3, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 1, 2021 | SOU EXTENSION 1 GRANTED |
| Wednesday, December 1, 2021 | SOU EXTENSION 1 FILED |
| Wednesday, December 1, 2021 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 1, 2021 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, April 6, 2021 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, April 6, 2021 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 17, 2021 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, March 1, 2021 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 17, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, February 17, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, February 17, 2021 | ASSIGNED TO LIE |
| Friday, November 13, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, May 14, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, May 14, 2020 | NON-FINAL ACTION E-MAILED |
| Thursday, May 14, 2020 | NON-FINAL ACTION WRITTEN |
| Monday, March 30, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, March 30, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, March 30, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, October 5, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, October 5, 2019 | NON-FINAL ACTION E-MAILED |
| Saturday, October 5, 2019 | NON-FINAL ACTION WRITTEN |
| Saturday, September 28, 2019 | ASSIGNED TO EXAMINER |
| Saturday, August 31, 2019 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, August 19, 2019 | NEW APPLICATION ENTERED |